Chilean President Approves AstraZeneca Vaccine Trials

Chilean President Sebastian Piñera announced on Thursday morning that the nation’s health regulator had given full approval for clinical trials of the AstraZeneca COVID-9 vaccine.

Chilean President Sebastian Piñera announced on Thursday morning that the nation’s health regulator had given full approval for clinical trials of the AstraZeneca COVID-9 vaccine.

During a press conference in capital Santiago, President Piñera told local reporters that the AstraZeneca trial would follow one by United States’ Johnson & Johnson that is already underway and another by China’s Sinovac, whose first vaccine does arrived in the country on Wednesday night.

The conservative leader explained that his government had been working “for months” to ensure sufficient and timely access to COVID vaccines, and hoped to start rolling them out to vulnerable populations “in the first few months of next year.”

“We all know that a safe, effective and readily-available vaccine to all those who need it will be a huge contribution to the fight against Coronavirus,” he said.

The Chilean government has previously said it had reserved 14.4 million doses of the AstraZeneca vaccine and incorporated a clause into its agreement for the Sinovac trial for the preferential purchase of 20 million doses.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.